Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BELLUS Health Inc BLUSD


Primary Symbol: T.BLU

BELLUS Health Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. The Company's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The Company has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The Company is focused on initiating Phase III program. The Company is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.


TSX:BLU - Post by User

Bullboard Posts
Post by webpiloton Jul 12, 2012 3:07pm
226 Views
Post# 20108019

Here is a misleading article on 3 remaining trials

Here is a misleading article on 3 remaining trials

If you are interested in solving Alzheimer's please read the following article.  First of all there is a feeling of desperation in the words of the author.  It is a comprehensive writing of what is going on in trials that are concluding in the immediate future.  For example, one of the drugs is attempting to clear the beta amyloid, I don't know how much that will do because clearing it is one thing but unless you can stop the formation of the beta amyloid you are not accomplising much and it will be very very expensive.  Researchers know what causes the formation of beta amyloid or at least some do but so far it has been sweept under the carpet, there are plenty of articles on this.  Another of the drugs is trying to stop the atrophy of the brain.  In fact one of the researchers says that that is startling.  Correct me if I am wrong but isn't that what Vivimind already does and has already been proven in clinical trials that it stops the atrophy by 68% and NRM8499 is expected to stop atrophy by 100%.

What am I missing here, well it is not only a medical mystery but also a political football.

https://latino.foxnews.com/latino/health/2012/07/12/last-drugs-that-could-slow-alzheimer-disease/

Bellus should hold off with any partnership until the results of at least 2 of the above mentioned trials are disclosed .  The above mentioned trials offer solutions that are far beyond the financial means of nearly everyone.  

Bullboard Posts